DEXBROMPHENIRAMINE MALEATE Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Dexbrompheniramine Maleate, and when can generic versions of Dexbrompheniramine Maleate launch?
Dexbrompheniramine Maleate is a drug marketed by Avanthi Inc and is included in one NDA.
The generic ingredient in DEXBROMPHENIRAMINE MALEATE is dexbrompheniramine maleate; pseudoephedrine sulfate. There are seven drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the dexbrompheniramine maleate; pseudoephedrine sulfate profile page.
Summary for DEXBROMPHENIRAMINE MALEATE
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Formulation / Manufacturing: | see details |
DailyMed Link: | DEXBROMPHENIRAMINE MALEATE at DailyMed |
US Patents and Regulatory Information for DEXBROMPHENIRAMINE MALEATE
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Avanthi Inc | DEXBROMPHENIRAMINE MALEATE AND PSEUDOEPHEDRINE SULFATE | dexbrompheniramine maleate; pseudoephedrine sulfate | TABLET, EXTENDED RELEASE;ORAL | 078648-001 | Feb 27, 2013 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |